This study provides evidence that MT effectively ameliorates NP by modulating inflammation and RNA m6A methylation in the spinal cord via the SOCS1/TLR4 pathway.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: